Rhodin, Kristen E.
Liu, Annie
Bartholomew, Alex
Kramer, Ryan
Parameswaran, Anika
Uronis, Hope
Strickler, John
Hsu, David
Morse, Michael A.
Shah, Kevin N.
Herbert, Garth
Zani, Sabino
Nussbaum, Daniel P.
Allen, Peter J.
Lidsky, Michael E.
Funding for this research was provided by:
National Cancer Institute (F32CA268527)
National Center for Advancing Translational Sciences (KL2 TR002554)
National Institute of Allergy and Infectious Diseases (1R38AI140297)
Article History
Received: 2 February 2023
Accepted: 11 April 2023
First Online: 15 May 2023
Disclosure
: K. Rhodin is supported by NIH 1R38AI140297. A. Liu is supported by NIH F32CA268527. K. Rhodin and A. Liu both acknowledge support from the Duke Cancer Institute as part of the P30 Cancer Center Support Grant (grant ID: P30 CA014236). M. Lidsky receives funding support from the Department of Surgery and Duke Cancer Institute, the Duke School of Medicine Strong Start Award, The American College of Surgeons National Surgeon Scientist Program, and the Cholangiocarcinoma Foundation Research Fellowship Award. This project also was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant KL2 TR002554 (M. Lidsky). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. J. Strickler declares Abbvie: consulting (self); research grant (institution). Amgen: consulting (self); research grant (institution). AstraZeneca: consulting (self); research grant (institution). Beigene: consulting (self); research grant (institution). Daiichi-Sankyo: consulting (self); research grant (institution). Eli Lilly: consulting (self); research grant (institution). GSK: consulting (self); research grant (institution). Natera: consulting (self). Pfizer: consulting (self). Roche/Genentech: consulting (self); research grant (institution). Seagen: consulting (self); research grant (institution). Takeda: consulting (self). Viatris: consulting (self). Silverback Therapeutics: consulting (self); research grant (institution). Astar D3: research grant (institution). Bayer: consulting (self); research grant (institution). Curegenix: research grant (institution). Gossamer Bio: research grant (institution). Leap Therapeutics: research grant (institution). Nektar: research grant (institution). Sanofi: research grant (institution).